Glanbia Q3 2025: 3.3% Revenue Growth, 14.3% Performance Nutrition Surge, Upgraded Full‑Year Guidance
Glanbia PLC’s Q3 2025 earnings hit a 3.3% revenue lift, led by a 14.3% Optimum Nutrition sales jump, prompting an upgraded full‑year guidance that’s boosting shares to a 52‑week high.
2 minutes to read





